|
|
| |
Keeping in touch with the students that work for us is a priority at SUPERVALU Pharmacies. Students have a chance to meet with our recruiters and Pharmacy District Managers at a variety of campus events through out the school year. In addition, we use e-mail communication as a way to keep students informed and in touch with the company. Below are just a few examples of the communications we send out to our students.
|
| Newsletters (PDF format) |
|
June 2008
Over the past 30 years the prevalence of obesity has significantly increased. In 2004, over 30% of American adults were classified as obese. Obesity is associated with numerous chronic illnesses including diabetes, hypertension, hyperlipidemia, and obstructive sleep apnea. The best way to lose weight is calorie reduction and exercise. When these techniques are ineffective, however, prescription weight-loss medications may be employed under the supervision of a physician. Three FDA-approved medications for obesity are phentermine, sibutramine, and orlistat...
May 2008
Allergic rhinitis, more commonly known as “hay fever” or “allergies”, affects about 58 million Americans, making it the sixth most prevalent chronic illness in the United States. Each year allergic rhinitis accounts for 100 million days of lost work and 1.5 million days of missed school. It also accounts for 5.9 billion dollars in direct health care costs each year, including 16.7 million physician visits, and 3.8 billion dollars of indirect costs, such as missed school and work...
April 2008
The ARx pharmacy team is pleased to announce the successful completion of the ARx application deployment effort, the company’s new prescription filling system. All SUPERVALU Pharmacies (920 in-store pharmacies nationwide) are now operating a common pharmacy management system.
SUPERVALU Pharmacies held a Companywide Meeting on April 9 and 10 to celebrate the completion and give out some well deserved thank you’s and awards for a job well done. The decade long development of ARX included new hardware designs and 7 new patents for our technology...
|
|
|
|
